The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
D000818:Animals; D001780:Blood Coagulation Tests; D002196:Capillaries / Q000293:injuries; D002199:Capillary Permeability / Q000187:drug effects; D003517:Cyclopentanes / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000473:pathology; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008643:Mesentery; D011758:Pyrroles / Q000627:therapeutic use; D051381:Rats; D012867:Skin / Q000098:blood supply; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy
D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds